Clinical Database and Biobank of Patients With Gynecologic Neoplasms
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01267851 |
Recruitment Status
: Unknown
Verified December 2010 by Huazhong University of Science and Technology.
Recruitment status was: Recruiting
First Posted
: December 29, 2010
Last Update Posted
: February 15, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Cervical Cancer Ovarian Cancer Endometrial Cancer Choriocarcinoma Uterine Fibroids Endometriosis |
The database contains clinical and epidemiologic information about patients with gynecologic neoplasms, such as cervical carcinoma, ovarian carcinoma, etc. With the data gathered from this database, the investigators could further demonstrate the etiology, risk factor, clinical treatment, and other aspects of the complicated gynecologic diseases. The cervical cancer database v1.10 including more than 10,000 cases and more than 200 variables has been established.
The biobank collects blood, fluids, tissue samples, and related clinical data from consenting patients with gynecologic neoplasms, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis. Besides, blood samples of population-based healthy people with informed consent are also collected.
Study Type : | Observational |
Official Title: | A Large Multicentre Clinical Database and Biobank of Patients With Gynecologic Neoplasms |
Study Start Date : | January 1999 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- patients with informed consent;
- patients with gynecologic diseases;
- patients with intact clinical and pathological information
Exclusion Criteria:
- not included in the inclusion criteria

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01267851
Contact: Ma Ding, M.D. | 86-27-8362681 | dma@tjh.tjmu.edu.cn |
China, Hubei | |
Tongji Hospital of HUST | Recruiting |
Wuhan, Hubei, China | |
Contact: Ma Ding, M.D. 86-27-8362681 dma@tjh.tjmu.edu.cn |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Ding Ma, Cancer Biology Research Center of Tongji Hospital |
ClinicalTrials.gov Identifier: | NCT01267851 History of Changes |
Other Study ID Numbers: |
GM2010-06-02 |
First Posted: | December 29, 2010 Key Record Dates |
Last Update Posted: | February 15, 2011 |
Last Verified: | December 2010 |
Keywords provided by Huazhong University of Science and Technology:
gynecologic disease |
Additional relevant MeSH terms:
Genital Diseases, Female Neoplasms Uterine Cervical Neoplasms Endometrial Neoplasms Endometriosis Leiomyoma Myofibroma Choriocarcinoma Genital Neoplasms, Female Uterine Neoplasms Urogenital Neoplasms Neoplasms by Site Uterine Cervical Diseases |
Uterine Diseases Neoplasms, Muscle Tissue Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms, Connective Tissue Connective Tissue Diseases Trophoblastic Neoplasms Neoplasms, Germ Cell and Embryonal Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Pregnancy Complications, Neoplastic Pregnancy Complications |